ECP 2018 Final Programme

Wednesday, 12 Sept 111 ECP 2018 · Bilbao Poster Presentations a Wednesday PS-20 e Wednesday, 12 September 2018 PS-20 Poster Session Digestive Diseases Pathology – GI Chairs: Arzu Ensari, Turkey Alessandro Lugli, Switzerland Anne Jouret-Mourin, Belgium Magali Svrcek, France 001 Various histologic patterns of terminal ileitis and their diagnostic significance Aslihan Yavas, Turkey M. T. Aydugan, S. Kiremitci, B. Savas, H. Cetinkaya, A. Ensari 002 Lymphocytic gastritis: what is the underlying scenario? Fadime Gul Salman, Turkey A. Yavas, S. Kiremitci, B. Savas, A. Ensari 003 Histological factors selecting high-risk patients in colorectal cancer. Could they have a prognostic utility? Caterina Fumagalli, Spain R. Teres Lleida, J. Solis Villegas, I. J. Gich Saladich, E. M. Targarona Soler, J. C. Pernas Canadell, D. Paez Lopez-Bravo, V. Fusté Chimisana, J. Szafranska 004 Serrated changes, lesions and adenocarci- noma in inflammatory bowel disease patients – single institution molecular and immunohistochemical study Katerina Kamaradova, Czech Republic H. Vosmikova, K. Sieglova, I. Tacheci, J. Laco 005 Synchronous tumours in patients with GISTs Madalina Bercea, Romania A. Dema, S. Taban, M. Iacob, D. Anderco, S. Olariu, F. Lazar 006 Spheroid-type intestinal amyloidosis. A case report Itziar de La Peña Navarro, Spain E. Palacios Lázaro, L. Blasco Santana, L. Guerra Pastrian, M. C. Méndez Diaz, I. Ruz-Caracuel 007 Early oesophageal adenocarcinoma: IMP3 expression in association with depth of invasion and lymphatic spread Dita Ulase, Latvia P. S. Plum, H. Loeser, I. Strumfa, E. Bollschweiler, A. Quaas, A. Hölscher 008 Colorectal carcinomas and DNA mismatch repair status – a statistical analysis of 123 consecutive cases from a tertiary center Irina Alexandra Ostahi, Romania F. Andrei, V. Enache, S. Enache, F. Vasilescu, L. Ali, V. T. Moldovan, G. Becheanu 009 Sporadic duodenal gastrinoma with d418d polymorphism in exon 9 of men1 gene Mihaela Sincu, Romania I. Jung, S. Haruhiko, C. Borz, S. Gurzu 011 Microsatellite instability status in gastric cancer: why and how? Maria Carolina Martinez Ciarpaglini, Spain T. Fleitas, M. Llorca-Cardeñosa, R. Mengual, M. Gil, F. Carrasco, C. Mongort, V. Gambardella, D. Roda, R. Susana, A. Cervantes, G. Ribas 012 Impact of cancer associated fibroblasts in oesophageal adenocarcinomas Jose A. Galvan, Switzerland J. Wiprächtiger, D. Kroell, C. A. Seiler, R. Langer 013 Is revision of cut-off values needed when using immunohistochemical staining for CD3 lymphocytes in histopathological diagnosis of lymphocytic colitis? Louise Clausen, Denmark A.-M. Kanstrup Fiehn, U. Engel, S. Wildt, L. K. Munch, P. Engel 014 Evaluation of the abnormal p53 protein expression as a predictor of colorectal neoplastic progression for patients with inflammatory bowel disease Magali Svrcek, France G. Deniziaut, J. Kirchgesner, L. Beaugerie, J.-F. Fléjou